Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
Uncover how beverage producers are improving throughput, reducing downtime, and making their operations more sustainable by ...
Led by CEO Harry Rowland, VahatiCor is developing the A-Flux coronary sinus reducer implant for coronary microvascular dysfunction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results